Zobrazeno 1 - 10
of 24
pro vyhledávání: '"J.J. Bjerre-Bastos"'
Autor:
Henning B. Nielsen, Christian S. Thudium, Abigail L. Mackey, Inger Byrjalsen, J.J. Bjerre-Bastos, Asger Reinstrup Bihlet, Morten A. Karsdal, Mikael Boesen, Jeppe Ragnar Andersen
Publikováno v:
European Journal of Applied Physiology. 121:2799-2809
To investigate acute changes in biochemical markers of bone and cartilage turnover in response to moderate intensity exercise with and without joint impact in healthy human subjects. A randomized, cross-over, exploratory, clinical study was conducted
Autor:
Henning Bliddal, Mikael Boesen, Jeppe Ragnar Andersen, Asger Reinstrup Bihlet, J.J. Bjerre-Bastos, Morten Karsdal, Anne-Christine Bay-Jensen
Publikováno v:
Translational Sports Medicine. 3:384-394
Autor:
J.J. Bjerre-Bastos, C. Sejersen, H.B. Nielsen, M. Boesen, N.H. Secher, G. Distajo, V. Flood, Y. Henrotin, M. Uebelhoer, A. Mackey, P. Krustrup, C.-C. Kitchen, E.E. Petersen, C.S. Thudium, J.R. Andersen, A.R. Bihlet
Publikováno v:
Osteoarthritis and Cartilage. 30:S102-S103
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C.P. Miller, J.J. Bjerre-Bastos, S.S. Groen, S.H. Nielsen, A.C. Bay-Jensen, S. á Rógvi, J.R. Andersen, A.R. Bihlet
Publikováno v:
Osteoarthritis and Cartilage. 30:S103
Autor:
M.A. Karsdal, C. Christiansen, J.J. Bjerre-Bastos, Y. Li, Asger Reinstrup Bihlet, Jeppe Ragnar Andersen
Publikováno v:
Osteoarthritis and Cartilage. 29:S241-S242
Autor:
Asger Reinstrup Bihlet, J.J. Bjerre-Bastos, Morten A. Karsdal, Henning B. Nielsen, Abigail L. Mackey, Mikael Boesen, Jeppe Ragnar Andersen, Yi He, Anne-Christine Bay-Jensen
Publikováno v:
Osteoarthritis and Cartilage Open, Vol 2, Iss 2, Pp 100060-(2020)
Bjerre-bastos, J J, Nielsen, H B, Andersen, J R, He, Y, Karsdal, M, Bay-jensen, A, Boesen, M, Mackey, A L & Bihlet, A R 2020, ' Evaluation of serum ARGS neoepitope as an osteoarthritis biomarker using a standardized model for exercise-induced cartilage extra cellular matrix turnover ', Osteoarthritis and Cartilage Open, vol. 2, 100060 . https://doi.org/10.1016/j.ocarto.2020.100060
Bjerre-bastos, J J, Nielsen, H B, Andersen, J R, He, Y, Karsdal, M, Bay-jensen, A, Boesen, M, Mackey, A L & Bihlet, A R 2020, ' Evaluation of serum ARGS neoepitope as an osteoarthritis biomarker using a standardized model for exercise-induced cartilage extra cellular matrix turnover ', Osteoarthritis and Cartilage Open, vol. 2, 100060 . https://doi.org/10.1016/j.ocarto.2020.100060
Summary Objective To propose a standardized model for exercise-induced cartilage turnover and investigate residual levels and dynamics of biomarker serum ARGS (sARGS) in primary osteoarthritis (OA) patients and a supportive group of young healthy sub
Autor:
Asger Reinstrup Bihlet, Jeppe Ragnar Andersen, J.J. Bjerre-Bastos, Inger Byrjalsen, Morten A. Karsdal, Anne-Christine Bay-Jensen
Publikováno v:
Seminars in arthritis and rheumatism. 50(6)
Objectives Clinical trials of new disease-modifying treatments for osteoarthritis should demonstrate a positive effect on a functional outcome or reduction in joint failure in order to be considered successful. Total joint replacement (TJR) surgery m
Autor:
Anne-Christine Bay-Jensen, J.J. Bjerre-Bastos, Jeppe Ragnar Andersen, Bente Juel Riis, Asger Reinstrup Bihlet, Claus Christiansen, Inger Byrjalsen, Morten A. Karsdal
Publikováno v:
Poster Presentations.
Background Osteoarthritis (OA) can lead to joint failure and ultimately total joint replacement (TJR). Identifying risk-factors of developing joint failure is of interest for clinicians and researchers. Currently late-stage clinical trial design for
Autor:
Morten A. Karsdal, Asger Reinstrup Bihlet, Inger Byrjalsen, J.J. Bjerre-Bastos, Jeppe Ragnar Andersen
Publikováno v:
Saturday, 15 June 2019.
Background: Development of new disease-modifying drugs in OA (DMOADs) is complicated by heterogeneous study populations and insensitive endpoints of structural change and symptoms, and discordance between structural disease severity and reported symp